Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded. [Operator instructions] I would now like to turn the call over to Mr. Peter ...

Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive Officer Matt ...

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...

Q1 2025. Management View. CEO Robert Mauch highlighted strong Q1 performance with 13% revenue growth and a 14% increase in adjusted EPS.

Kim Kelderman; Chief Executive Officer, Chief Operating Officer, Director; Bio-Techne Corp James Hippel; Chief Financial Officer, Executive Vice President - Finance; Bio-Techne Corp Good morning, and ...

Super Micro Computer, QUALCOMM, Cisco Systems, Fortinet, Onsemi, Monolithic Power Systems, and Cadence Design Systems are the seven 5G stocks to watch today, according to MarketBeat’s stock screener ...

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

Welcome to Edition 7.30 of the Rocket Report! The US government relies on SpaceX for a lot of missions. These include ...

Pharmaceuticals announced that Norgine Pharmaceuticals has commercially launched PEDMARQSI in Germany. “Until now, there have ...